|
Sucampo Presents Detailed Results of Positive Phase 3 Trial of Lubiprostone in Opioid-Induced Bowel Dysfunction (OBD)
Sucampo Pharmaceuticals, Inc. today announced the presentation of positive data from a Phase 3 clinical trial of lubiprostone for the treatment of opioid-induced bowel dysfunction , at Digestive Disease Week 2012, held in San Diego, California.
finance.yahoo.com
Cocoa products may offer fiber source for consumers
“The regular addition of two servings of cocoa products, providing 2.26 and 6.60 g of total non-starch polysaccharides per day, to a typical Spanish diet is an efficacious alternative to increase fiber intake to recommended levels without leading to an increase in body weight when consumed during 4 weeks,” reported researchers from the Spanish National Research Council (CSIC).
www.nutraingredients-usa.com
How to Deal With IBS or "Spastic Colon"
Irritable Bowel Syndrome – sometimes called "spastic colon" or "nervous colon" -- is a chronic gastro-intestinal problem that can cause a range of annoying and embarrassing symptoms.
www.thirdage.com
AGA presents cutting-edge research during DDW®
( American Gastroenterological Association ) Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week 2012, the largest and most prestigious gastroenterology meeting, from May 19-22, 2012, at the San Diego Convention Center. DDW, the annual meeting of the American Gastroenterological Association (AGA) Institute, is jointly sponsored by the American ...
www.eurekalert.org
Cubist sees positive constipation drug candidate data
Cubist Pharmaceuticals Inc. (Nasdaq: CBST) said two of its Phase 2 studies of the drug candidate CB-5945 in patients with chronic non-cancer pain and opioid-induced constipation have met their primary endpoints, and Phase 3 studies are expected to start by the end of this year.
www.masshightech.com
|
